https://www.prnewswire.com/news-releases/merck-kgaa-darmstadt-germany-reports-topline-data-for-bintrafusp-alfa-as-second-line-monotherapy-treatment-in-biliary-tract-cancer-301247680.html
Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy...
/PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047...